The Complete 5-Bucket Guide to Choosing an Electronic Lab Notebook (ELN)

Start here, not with a vendor list

Most people start an electronic lab notebook (ELN) search by collecting vendor names and comparing feature lists. That's backwards. What you should start with is your own requirements: how ambitious you are with the data, what shape your R&D takes, and what you already run alongside it. Two teams with identical feature checklists can still land on different right answers, because their requirements differ.

This guide is built around five decision buckets. The first three each follow directly from a question you answer about your own lab. The fourth bucket isn't driven by a question about your lab at all, it's about the vendor. The fifth is the one place you're mostly free to decide later.

1. Ambition — find-and-preserve, or aggregate-and-model?
2. Orientation — discovery, samples and tests, or ingredients and products?
3. Regulatory exposure — GxP, IP, and outside parties, or none of those?
4. Vendor hygiene — R&D, IT, and commercial checks that can still eliminate a supplier.
5. Add-ons you can defer — native, bolted on, or a separate tool?

If you haven't read How to Choose Lab Notebook Software — The One Question That Matters, here's the two-line summary: the same entry can end up stored as free text, as structured fields, or as full database columns, and which one you have determines whether you can search, filter, or precisely audit your data later. Worth the five-minute read first; everything below builds on it.

1. Ambition

Answer this honestly on why you want an ELN before anything else.

1. Do you mainly want to easily find back what was done, and be confident it's safely backed up?
2. Or do you want to eventually combine historical data across experiments to build predictive models, feed dashboards, or support AI-assisted analysis?

These aren't the same project. The first is served well by decent search and reliable storage. The second needs structured, consistent, schema-backed data from day one. You can't retroactively make three years of free-text entries easily machine-readable by deciding you want to, later. Technology has improved a lot in the last few years to do this, but if you want high fidelity of data and if there's real ambition to model or aggregate data, it is best designed in from the start.

The second path also carries a cost that's easy to underestimate: change management, not just technology. Structured, schema-backed data means scientists entering results into fixed fields instead of writing freely, and some will resist that. A format that makes data easy to aggregate later is, by definition, a format that gives the person entering it less freedom now. You need to plan for overcoming that resistance as a real part of the decision, not a rollout detail to handle after the fact.

By setting your ambition level, you are influencing two decisions below.

• Architecture of ELN (binder / canvas / compliance). Sets whether you can filter, aggregate, and audit data later, not just search it.
• Terminology and format enforcement. Determines, for example, whether "ethanol" and "EtOH" are recognised as the same value later, covered in depth in the companion piece.

Most purchase regret traces back to this bucket. Architecture is the single decision that is impossible to reverse once you're live.

2. Orientation

Laboratory work in the process industry tends to fall into one of three shapes, or a genuine blend of them.

Many R&D organizations, especially in chemicals, materials, and CPG, genuinely span more than one. If that's you, work out where the bulk of your volume sits, and where your current pain is sharpest. If 80% of your work is formulation and discovery is a side activity, choose a formulation-strength system and accommodate discovery work in the system.

A CRO that mainly runs chemical analytical measurements is likely samples and tests oriented, a lab that does basic research is likely discovery and hypothesis oriented, and a private label manufacturer for retail supermarket is likely ingredient and products oriented. Your orientation influences your choice.

• Enterprise system connectivity (PLM, LIMS, and others). Orientation is a strong hint, not the only driver. Formulation tends to need PLM, sample-and-test tends to need LIMS. Other Enterprise systems like EHS, scheduling, and asset management often matter too, and connectivity to these systems might be useful irrespective of the orientation.
• Template flexibility. Follows directly from orientation: discovery wants freedom to write; sample-and-test and formulation want tighter templates.
• Instrument and equipment data capture. This is probably a universal requirement although one may argue that this is most important in a CRO like situation.

Here is how to think about what you need

Your ELN needs to be superior in managing your core work. Get this bucket wrong and the workaround shows up within months, usually as a spreadsheet on the side.

3. Regulatory / compliance and organizational exposure

A third set of questions, separate from ambition and orientation, and worth asking directly.

• Does your work fall under GxP, GMP, or GLP?
• Is your IP sensitive enough that you need to prove exactly who touched a value, and when?
• Do you regularly share data with outside parties, CROs, contract manufacturers, or regulators, who need scoped, defensible access?

If the answer is yes to any of these, everything in this bucket moves from optional to critical, regardless of your ambition or lab orientation. A GxP-regulated discovery lab and a GxP-regulated formulation lab have very different orientations, but nearly identical requirements here.

• Audit depth (page / snapshot / cell-by-cell). Decides how precisely you can reconstruct who changed what, and when.
• Validation burden (IQ/OQ/PQ support). Shapes how long implementation takes before the system can be trusted.
• Multi-tenancy and data isolation. An architecture-level guarantee that one project's data can never structurally reach another's.
• External access governance. A permission-level question: can this specific partner see this specific record. Distinct from data isolation above, which is architecture-level, not a granted permission.
• Workflow orchestration and review. Enforces step order within a protocol, and governs who signs off once work is finished (PI review, QA sign-off, e-signatures).

Skip this bucket almost entirely if your regulatory exposure is genuinely low. Adding it anyway, because a vendor bundles it by default, buys you friction with no matching benefit. Make sure you can disable it in case it is in-built and does not cost an arm and a leg extra.

4. Vendor, security, and commercial

This bucket is entirely about the vendor: how much you can trust them, and how much you'll depend on them.

One quick check before the real items: uptime and 24/7 access, operational analytics on usage, basic internal collaboration, and basic keyword search are roughly the same across any reputable vendor. The real items split by who in your organization actually needs to weigh in.

4a. R&D-led, with IT support

These depend on what R&D actually wants to do with the system, and R&D is the only party equipped to judge them, even though IT needs to verify feasibility.

• API and extensibility. Governs whether you can connect the notebook to your own tools.
• Data export and portability. Decides what happens the day you leave this vendor, not what happens while you use it. It's your data; IT verifies the mechanics, but R&D should define what "leaving cleanly" needs to look like.
• UI feel (canvas, form, grid). Affects whether people actually use it or quietly work around it. No one but your prospective users can judge this well.
• Vendor roadmap. Determines whether the product keeps evolving in directions useful to your actual work.

Here is how to evaluate the importance of each feature

4b. IT-led

Pure security and infrastructure questions. Hand these off entirely; R&D input adds little here.

• Security certifications (SOC 2, ISO 27001). Confirms independently audited security practices, not just a vendor's word.
• Data residency and regulatory attestations. Confirms where data physically lives, and whether that can be restricted by region (e.g., GDPR), or, if relevant, whether 21 CFR Part 11 / GxP electronic signatures are validated.
• SSO and identity federation. Confirms the system fits your existing identity management, rather than becoming its own silo.
• Ecosystem lock-in (technical). Determines how deeply the vendor's stack is wired into your other systems, and how hard that is to unwind later.

4c. Commercial terms

The contract and the company behind it.

• Price and contract terms. Sets actual cost of ownership, not just the sticker price.
• Vendor viability. Determines whether the company behind the product is still around, financially, in five years.
• Support quality. Sets how fast problems actually get resolved once you're live.

Many of these are secondary if one thinks about core ELN functionality, but they might be necessary from a hygiene perspective so can still eliminate certain ELN vendors from the race.

5. Add-on capabilities (driven by your domain, easier to defer)

This is one bucket that you can decide on later if needed: items here can typically be added (at extra cost), swapped, or dropped later without touching your core notebook or your historical data. But there might be a constraint in terms of capability bundles.

For each item, there's a real decision beyond "do we need this": should it live natively in the notebook, as a bolted-on module, or as a separate best-of-breed tool you integrate with? Decide that deliberately, capability by capability, rather than by default because a vendor happened to bundle it.

• Inventory management. Tracks reagents and samples with a chain of custody.
• Design of experiments (DOE). Improves efficiency of systematic experimentation, useful well beyond early discovery.
• Analytics, from basic to advanced. Basic means descriptive stats; advanced means PCA, clustering, regression.
• Visualization, from basic to advanced. Basic means standard charts; advanced means interactive or multivariate plots.
• Reporting. Produces compliance dashboards and ad-hoc reports without manual assembly.
• Cheminformatics / bioinformatics / structure search. Lets you search and analyze by chemical or biological structure, not just text.
• Domain-specific tools. Covers work a generic notebook wasn't built for.
• Sample management. Tracks a sample and everything derived from it, not just the sample itself.
• Voice and hands-free data capture. Records observations by speaking, no keyboard, no removing gloves. A genuinely emerging capability, several vendors now build or integrate it.
• Built-in GenAI facilities. Native search, summarisation, or drafting inside the notebook, versus exporting to a separate AI tool.

Final note

Every capability in this guide has a cost, in money, complexity, or flexibility. The goal isn't to find the "best" ELN. It's to find the one that's best for your ambition, orientation and regulatory exposure.

To make it easy for you to do the selection, I have created a self-assessment form: write your own requirements first, then assess each vendor against them in discussions and demos.

Frequently asked questions

Why start from your own lab instead of a vendor list?

Two teams with identical feature checklists can still land on different right answers, because their ambition, lab orientation, and regulatory exposure differ. Vendor lists compare products. The five buckets decide which product you actually need.

What is the difference between find-and-preserve and aggregate-and-model?

Find-and-preserve means you mainly need to retrieve prior work and keep it safely backed up. Decent search and reliable storage are enough. Aggregate-and-model means you want to combine historical data across experiments for dashboards, predictive models, or AI-assisted analysis. That needs structured, schema-backed data from day one, and you cannot retrofit three years of free-text entries later.

When does GxP change which ELN you should select?

If your work falls under GxP, GMP, or GLP, or you need to prove who changed a value and when, audit depth, validation support, data isolation, external access, and formal review all move from optional to critical. A GxP discovery lab and a GxP formulation lab have different orientations, but nearly identical requirements in this bucket. If regulatory exposure is genuinely low, skip most of it.

What can wait until after you have chosen an ELN?

Add-on capabilities such as inventory, DOE, advanced analytics, visualisation, reporting, structure search, sample management, voice capture, and built-in GenAI can usually be added, swapped, or dropped later without touching the core notebook or historical data. Decide whether each should live natively, as a module, or in a separate tool, rather than taking a vendor bundle by default.